Literature DB >> 10827000

Regulation of MAP kinase pathway activity in vivo in human skeletal muscle.

A A Osman1, M Pendergrass, J Koval, K Maezono, K Cusi, T Pratipanawatr, L J Mandarino.   

Abstract

Insulin and exercise potently stimulate glucose metabolism and gene transcription in vivo in skeletal muscle. A single bout of exercise increases the rate of insulin-stimulated glucose uptake and metabolism in skeletal muscle in the postexercise period. The nature of the intracellular signaling mechanisms that control responses to exercise is not known. In mammalian tissues, numerous reports have established the existence of the mitogen-activated protein (MAP) kinase signaling pathway that is activated by a variety of growth factors and hormones. This study was undertaken to determine how a single bout of exercise and physiological hyperinsulinemia activate the MAP kinase pathway. The euglycemic-hyperinsulinemic clamp and cycle ergometer exercise techniques combined with percutaneous muscle biopsies were used to answer this question. In healthy subjects, within 30 min, insulin significantly increased MAP kinase [isoforms p42(MAPK) and p44(MAPK) (ERK1 and ERK2)] phosphorylation (141 +/- 2%, P < 0.05) and activity (177 +/- 5%, P < 0.05), and the activity of its upstream activator MEK1 (161 +/- 16%, P < 0.05). Insulin also increased the activity of the MAP kinase downstream substrate, the p90 ribosomal S6 kinase 2 (RSK2) almost twofold (198 +/- 45%, P < 0.05). In contrast, a single 30-min bout of moderate-intensity exercise had no effect on the MAP kinase pathway activation from MEK to RSK2 in muscle of healthy subjects. However, 60 min of exercise did increase extracellular signal-related kinase activity. Therefore, despite similar effects on glucose metabolism after 30 min, insulin and exercise regulate the MAP kinase pathway differently. Insulin more rapidly activates the MAP kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827000     DOI: 10.1152/ajpendo.2000.278.6.E992

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice.

Authors:  Kechun Tang; Teresa Pasqua; Angshuman Biswas; Sumana Mahata; Jennifer Tang; Alisa Tang; Gautam K Bandyopadhyay; Amiya P Sinha-Hikim; Nai-Wen Chi; Nicholas J G Webster; Angelo Corti; Sushil K Mahata
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

Review 2.  Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.

Authors:  Dierk H Endemann; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

3.  Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle.

Authors:  D Williamson; P Gallagher; M Harber; C Hollon; S Trappe
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

4.  NOX2 Inhibition Impairs Early Muscle Gene Expression Induced by a Single Exercise Bout.

Authors:  Carlos Henríquez-Olguín; Alexis Díaz-Vegas; Yildy Utreras-Mendoza; Cristian Campos; Manuel Arias-Calderón; Paola Llanos; Ariel Contreras-Ferrat; Alejandra Espinosa; Francisco Altamirano; Enrique Jaimovich; Denisse M Valladares
Journal:  Front Physiol       Date:  2016-07-14       Impact factor: 4.566

5.  Diabetes alters contraction-induced mitogen activated protein kinase activation in the rat soleus and plantaris.

Authors:  A Katta; D L Preston; S K Karkala; S Asano; S Meduru; S P Mupparaju; E Yokochi; Kevin M Rice; D H Desai; E R Blough
Journal:  Exp Diabetes Res       Date:  2008

6.  Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance.

Authors:  Atsunori Ueyama; Nobuhiro Ban; Masanori Fukazawa; Tohru Hirayama; Minako Takeda; Tatsuo Yata; Hiroyasu Muramatsu; Masaki Hoshino; Marii Yamamoto; Masao Matsuo; Yuka Kawashima; Tatsuhiko Iwase; Takehisa Kitazawa; Youichi Kushima; Yuichiro Yamada; Yoshiki Kawabe
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.